acebutolol has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Guo, X; Lai, B; Li, M; Luo, H; Ye, G; Zhong, Y | 1 |
| Appelhans, D; Klajnert-Maculewicz, B; Pulaski, L; Szulc, A; Voit, B | 1 |
2 other study(ies) available for acebutolol and Leukemia
| Article | Year |
|---|---|
A Novel Multicolor Flow Cytometry Scoring System for the Diagnosis and Prognostic Stratification of Myelodysplastic Syndromes.
Topics: Ferric Compounds; Flow Cytometry; Humans; Leukemia; Leukocyte Count; Maltose; Myelodysplastic Syndromes; Prognosis | 2022 |
Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytarabine; Dendrimers; Drug Delivery Systems; Drug Resistance, Neoplasm; Equilibrative Nucleoside Transporter 1; Humans; Leukemia; Leukocytes, Mononuclear; Maltose; Polypropylenes | 2016 |